Clinomics Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
ByungChul Kim
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | no data |
CEO ownership | 1.6% |
Management average tenure | no data |
Board average tenure | no data |
Recent management updates
CEO
ByungChul Kim (58 yo)
no data
Tenure
Mr. ByungChul Kim serves as Chief Executive Officer of Clinomics Inc. He is Genetics Expert. He has been ommercialized Asia’s first personalized genome analysis product (Theragen Etex HelloGene); Developed...